1.Fear Network Model in Panic Disorder: The Past and the Future
Psychiatry Investigation 2019;16(1):16-26
The core concept for pathophysiology in panic disorder (PD) is the fear network model (FNM). The alterations in FNM might be linked with disturbances in the autonomic nervous system (ANS), which is a common phenomenon in PD. The traditional FNM included the frontal and limbic regions, which were dysregulated in the feedback mechanism for cognitive control of frontal lobe over the primitive response of limbic system. The exaggerated responses of limbic system are also associated with dysregulation in the neurotransmitter system. The neuroimaging studies also corresponded to FNM concept. However, more extended areas of FNM have been discovered in recent imaging studies, such as sensory regions of occipital, parietal cortex and temporal cortex and insula. The insula might integrate the filtered sensory information via thalamus from the visuospatial and other sensory modalities related to occipital, parietal and temporal lobes. In this review article, the traditional and advanced FNM would be discussed. I would also focus on the current evidences of insula, temporal, parietal and occipital lobes in the pathophysiology. In addition, the white matter and functional connectome studies would be reviewed to support the concept of advanced FNM. An emerging dysregulation model of fronto-limbic-insula and temporooccipito-parietal areas might be revealed according to the combined results of recent neuroimaging studies. The future delineation of advanced FNM model can be beneficial from more extensive and advanced studies focusing on the additional sensory regions of occipital, parietal and temporal cortex to confirm the role of advanced FNM in the pathophysiology of PD.
Autonomic Nervous System
;
Connectome
;
Frontal Lobe
;
Limbic System
;
Neuroimaging
;
Neurotransmitter Agents
;
Occipital Lobe
;
Panic Disorder
;
Panic
;
Parietal Lobe
;
Rabeprazole
;
Temporal Lobe
;
Thalamus
;
White Matter
2.A physiology based model of heart rate variability
Wilhelm VON ROSENBERG ; Marc Oscar HOTING ; Danilo P MANDIC
Biomedical Engineering Letters 2019;9(4):425-434
Heart rate variability (HRV) is governed by the autonomic nervous system (ANS) and is routinely used to estimate the state of body and mind. At the same time, recorded HRV features can vary substantially between people. A model for HRV that (1) correctly simulates observed HRV, (2) reliably functions for multiple scenarios, and (3) can be personalised using a manageable set of parameters, would be a significant step forward toward understanding individual responses to external influences, such as physical and physiological stress. Current HRV models attempt to reproduce HRV characteristics by mimicking the statistical properties of measured HRV signals. The model presented here for the simulation of HRV follows a radically different approach, as it is based on an approximation of the physiology behind the triggering of a heart beat and the biophysics mechanisms of how the triggering process—and thereby the HRV—is governed by the ANS. The model takes into account the metabolisation rates of neurotransmitters and the change in membrane potential depending on transmitter and ion concentrations. It produces an HRV time series that not only exhibits the features observed in real data, but also explains a reduction of low frequency band-power for physically or psychologically high intensity scenarios. Furthermore, the proposed model enables the personalisation of input parameters to the physiology of different people, a unique feature not present in existing methods. All these aspects are crucial for the understanding and application of future wearable health.
Autonomic Nervous System
;
Biophysics
;
Heart Rate
;
Heart
;
Membrane Potentials
;
Neurotransmitter Agents
;
Physiology
;
Stress, Physiological
;
Vital Signs
3.Neuroimmune interactions and kidney disease
Sho HASEGAWA ; Tsuyoshi INOUE ; Reiko INAGI
Kidney Research and Clinical Practice 2019;38(3):282-294
The autonomic nervous system plays critical roles in maintaining homeostasis in humans, directly regulating inflammation by altering the activity of the immune system. The cholinergic anti-inflammatory pathway is a well-studied neuroimmune interaction involving the vagus nerve. CD4-positive T cells expressing β2 adrenergic receptors and macrophages expressing the alpha 7 subunit of the nicotinic acetylcholine receptor in the spleen receive neurotransmitters such as norepinephrine and acetylcholine and are key mediators of the cholinergic anti-inflammatory pathway. Recent studies have demonstrated that vagus nerve stimulation, ultrasound, and restraint stress elicit protective effects against renal ischemia-reperfusion injury. These protective effects are induced primarily via activation of the cholinergic anti-inflammatory pathway. In addition to these immunological roles, nervous systems are directly related to homeostasis of renal physiology. Whole-kidney three-dimensional visualization using the tissue clearing technique CUBIC (clear, unobstructed brain/body imaging cocktails and computational analysis) has illustrated that renal sympathetic nerves are primarily distributed around arteries in the kidneys and denervated after ischemia-reperfusion injury. In contrast, artificial renal sympathetic denervation has a protective effect against kidney disease progression in murine models. Further studies are needed to elucidate how neural networks are involved in progression of kidney disease.
Acetylcholine
;
Arteries
;
Autonomic Nervous System
;
Cholinergic Neurons
;
Homeostasis
;
Humans
;
Immune System
;
Inflammation
;
Kidney Diseases
;
Kidney
;
Macrophages
;
Nervous System
;
Neurotransmitter Agents
;
Norepinephrine
;
Optogenetics
;
Physiology
;
Receptors, Adrenergic
;
Receptors, Nicotinic
;
Reperfusion Injury
;
Spleen
;
Sympathectomy
;
Sympathetic Nervous System
;
T-Lymphocytes
;
Ultrasonography
;
Vagus Nerve
;
Vagus Nerve Stimulation
4.Three Gaseous Neurotransmitters, Nitric oxide, Carbon Monoxide, and Hydrogen Sulfide, Are Involved in the Neurogenic Relaxation Responses of the Porcine Internal Anal Sphincter.
Oladayo FOLASIRE ; Kylie A MILLS ; Donna J SELLERS ; Russ CHESS-WILLIAMS
Journal of Neurogastroenterology and Motility 2016;22(1):141-148
BACKGROUND/AIMS: The internal anal sphincter (IAS) plays an important role in maintaining continence and a number of neurotransmitters are known to regulate IAS tone. The aim of this study was to determine the relative importance of the neurotransmitters involved in the relaxant and contractile responses of the porcine IAS. METHODS: Responses of isolated strips of IAS to electrical field stimulation (EFS) were obtained in the absence and presence of inhibitors of neurotransmitter systems. RESULTS: Contractile responses of the sphincter to EFS were unaffected by the muscarinic receptor antagonist, atropine (1 muM), but were almost completely abolished by the adrenergic neuron blocker guanethidine (10 muM). Contractile responses were also reduced (by 45% at 5 Hz, P < 0.01) following desensitisation of purinergic receptors with alpha,beta-methylene-ATP (10 muM). In the presence of guanethidine, atropine, and alpha,beta-methylene-ATP, the remaining relaxatory responses to EFS were examined. These responses were not altered by the cyclooxygenase inhibitor, indomethacin (5 muM), the vasoactive intestinal polypeptide receptor antagonist, [D-p-Cl-Phe6,Leu17]-vasoactive intestinal peptide (PheLeu-VIP; 100 nM), or the purinoceptor antagonists, 8-phenyltheophyline (P1 receptors) or suramin (P2 receptors). However, relaxation responses were reduced by Nomega-nitro-L-arginine (L-NNA; 100 muM), an inhibitor of nitric oxide synthesis (40-50% reduction), zinc protoprophyrin IX (10 muM), an inhibitor of carbon monoxide synthesis (20-40% reduction), and also propargylglycine (30 muM) and aminooxyacetic acid (30 muM), inhibitors of hydrogen sulphide synthesis (15-20% reduction). CONCLUSIONS: Stimulation of IAS efferent nerves releases excitatory and inhibitory neurotransmitters: noradrenaline is the predominant contractile transmitter with a smaller component from ATP, whilst 3 gases mediate relaxation responses to EFS, with the combined contributions being nitric oxide > carbon monoxide > hydrogen sulfide.
Adenosine Triphosphate
;
Adrenergic Neurons
;
Aminooxyacetic Acid
;
Anal Canal*
;
Atropine
;
Autonomic Pathways
;
Carbon Monoxide*
;
Carbon*
;
Gases
;
Guanethidine
;
Hydrogen Sulfide*
;
Hydrogen*
;
Indomethacin
;
Neurotransmitter Agents*
;
Nitric Oxide*
;
Norepinephrine
;
Prostaglandin-Endoperoxide Synthases
;
Purinergic Antagonists
;
Receptors, Muscarinic
;
Receptors, Purinergic
;
Relaxation*
;
Suramin
;
Vasoactive Intestinal Peptide
;
Zinc
5.Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes.
The Korean Journal of Internal Medicine 2015;30(1):6-16
Hypoglycemia is a major barrier to achieving the glycemic goal in patients with type 2 diabetes. In particular, severe hypoglycemia, which is defined as an event that requires the assistance of another person to actively administer carbohydrates, glucagon, or take other corrective actions, is a serious clinical concern in patients with diabetes. If severe hypoglycemia is not managed promptly, it can be life threatening. Hypoglycemia-associated autonomic failure (HAAF) is the main pathogenic mechanism behind severe hypoglycemia. Defective glucose counter-regulation (altered insulin secretion, glucagon secretion, and an attenuated increase in epinephrine during hypoglycemia) and a lack of awareness regarding hypoglycemia (attenuated sympathoadrenal activity) are common components of HAAF in patients with diabetes. There is considerable evidence that hypoglycemia is an independent risk factor for cardiovascular disease. In addition, hypoglycemia has a significant influence on the quality of life of patients with diabetes. To prevent hypoglycemic events, the setting of glycemic goals should be individualized, particularly in elderly individuals or patients with complicated or advanced type 2 diabetes. Patients at high-risk for the future development of severe hypoglycemia should be selected carefully, and intensive education with reinforcement should be implemented.
Autonomic Nervous System/physiopathology
;
Biological Markers/blood
;
Blood Glucose/*drug effects/metabolism
;
Diabetes Mellitus, Type 2/blood/complications/diagnosis/*drug therapy/physiopathology
;
Health Knowledge, Attitudes, Practice
;
Humans
;
Hypoglycemia/blood/chemically induced/epidemiology/physiopathology/*prevention & control
;
Hypoglycemic Agents/*adverse effects
;
Incidence
;
Patient Education as Topic
;
Prevalence
;
Prognosis
;
Risk Assessment
;
Risk Factors
6.Intestinal Pseudoobstruction Caused by Chronic Lyme Neuroborreliosis. A Case Report.
David F SCHEFTE ; Tyge NORDENTOFT
Journal of Neurogastroenterology and Motility 2015;21(3):440-442
Chronic intestinal pseudoobstruction is often classified as idiopathic. The condition is associated with poor quality of life and high morbidity, and treatment options are often unsatisfactory. A case of chronic intestinal pseudoobstruction in a 66-year-old woman, presenting with back and abdominal pain, urinary retention and severe constipation is described. The patient lived in an area in which Lyme disease is endemic and had been bitten by ixodes ticks. Intrathecal synthesis of anti-borrelia IgM and IgG and lymphocytosis in the cerebrospinal fluid was found, consistent with chronic Lyme neuroborreliosis since symptoms had lasted for more than six months. The patient's gastrointestinal function recovered and the pain subsided significantly following treatment with antibiotics. Lyme neuroborreliosis (LNB) often results in palsy, but rarely affects the autonomic nervous system. Three patients have been described with intestinal pseudoobstruction due to acute LNB. However, this is the first described case of intestinal pseudoobstruction due to chronic Lyme neuroborreliosis. LNB must be suspected in patients with intestinal pseudoobstruction, in particular in patients who have been bitten by an ixodes tick and in patients living in an endemic area.
Abdominal Pain
;
Aged
;
Anti-Bacterial Agents
;
Autonomic Nervous System
;
Cerebrospinal Fluid
;
Constipation
;
Female
;
Humans
;
Immunoglobulin G
;
Immunoglobulin M
;
Intestinal Pseudo-Obstruction*
;
Ixodes
;
Lyme Disease
;
Lyme Neuroborreliosis*
;
Lymphocytosis
;
Paralysis
;
Quality of Life
;
Ticks
;
Urinary Retention
7.Psychological Stress in Chronic Intestinal Diseases.
Young Jae BYUN ; Chang Soo EUN
Hanyang Medical Reviews 2014;34(2):66-71
Psychological stress induces alterations in the function of the hypothalamic-pituitary-adrenal axis via corticotorphin releasing factor and alterations in the enteric nervous system via actions of the autonomic nervous system. Mucosal mast cells and adrenal glands release several inflammatory cytokines and cortisol, causing increased intestinal permeability. Increased intestinal permeability as well as increased inflammatory cytokines and hormones cause changes in bacterial-mucosal interactions, leading to the aggravation of disease activity and gastrointestinal symptoms in inflammatory bowel syndrome (IBD) and irritable bowel syndrome (IBS). Several studies have demonstrated that stress has an important roles in the pathogenesis of IBD and IBS. Personal traits, health beliefs and personal stress-coping mechanisms can also have adverse effects on the disease course of IBD and IBS. Stress reduction therapies have been adapted for treatment of IBD and IBS. Antidepressants and psychological therapies such as cognitive-behavior therapy, hypnotherapy, and multi-component psychological therapy have been used for control of disease activity and symptoms in IBD and IBS patients. The efficacy of such treatments is controversial, because there has not been an adequate standardization in treatment protocol, and studies suffer from the difficulties involved in selection of appropriate control groups, questions related to a high placebo effect, as well as differences in interpretation. Well-designed prospective controlled studies evaluating the role of stress in the pathogenesis of IBD and IBS and the role of stress reduction therapies are warranted for improvement of clinical treatments and outcomes.
Adrenal Glands
;
Antidepressive Agents
;
Autonomic Nervous System
;
Clinical Protocols
;
Cytokines
;
Enteric Nervous System
;
Humans
;
Hydrocortisone
;
Inflammatory Bowel Diseases
;
Intestinal Diseases*
;
Irritable Bowel Syndrome
;
Mast Cells
;
Permeability
;
Placebo Effect
;
Stress, Psychological*
;
Axis, Cervical Vertebra
8.Clinical Neuroanatomy and Neurotransmitter-Mediated Regulation of Penile Erection.
Junyang JUNG ; Hyun Woo JO ; Hyunseob KWON ; Na Young JEONG
International Neurourology Journal 2014;18(2):58-62
Erectile dysfunction (ED) has an adverse impact on men's quality of life. Penile erection, which is regulated by nerves that are innervated into the erectile tissue, can be affected by functional or anatomical trauma of the perineal region, including specific structures of the penis, causing ED. Penile erection is neurologically controlled by the autonomic nervous system. Therefore, it is of utmost importance to understand the neurogenic structure of the erectile tissue and the types of neurotransmitters involved in the penile erection process. Here, we highlight the basic clinical anatomy and erectile function of the penis. Understanding the clinical connotation of the relationship between penile erectile structure and function may provide fresh insights for identifying the main mechanisms involved in ED and help develop surgical techniques for the treatment of ED.
Autonomic Nervous System
;
Erectile Dysfunction
;
Male
;
Neuroanatomy*
;
Neurotransmitter Agents
;
Parasympathetic Nervous System
;
Penile Erection*
;
Penis
;
Quality of Life
9.Administration of Vitamin C in a Patient with Herpes Zoster: A case report.
Sung Hye BYUN ; Younghoon JEON
The Korean Journal of Pain 2011;24(2):108-111
Herpes zoster as a result of reactivated varicella-zoster virus is characterized by vesicular eruptions on skin and painful neuralgia in the dermatome distribution. Pain during an acute phase of herpes zoster has been associated with a higher risk of developing postherpetic neuralgia. The current therapies for herpes zoster including analgesics and sympathetic nerve block as well as antiviral agents are important to alleviate pain and prevent postherpetic neuralgia. However, in some cases, the pain does not respond well to these treatments. We had a case in which a patient with herpes zoster did not respond to conventional therapy so we attempted to administer intravenous infusion of vitamin C which resulted in an immediate reduction in the pain.
Analgesics
;
Antiviral Agents
;
Ascorbic Acid
;
Autonomic Nerve Block
;
Herpes Zoster
;
Herpesvirus 3, Human
;
Humans
;
Infusions, Intravenous
;
Neuralgia
;
Neuralgia, Postherpetic
;
Skin
;
Vitamins
10.Neuroleptic Malignant Syndrome Complicated with Acute Renal Failure Secondary to Quetiapine: A Case Report.
Journal of the Korean Society of Emergency Medicine 2010;21(2):278-281
Neuroleptic malignant syndrome (NMS) is an idiosyncratic, life-threatening complication of treatment with antipsychotic drugs, and this is characterized by fever, severe muscle rigidity and changes of the autonomic nervous system and mental status changes. We present the case of a 19-year-old woman with neuroleptic malignant syndrome that was complicated with acute renal failure secondary to quetiapine overdose. Emergency physicians should keep in mind the possibility of NMS when evaluating patients who present with fever.
Acute Kidney Injury
;
Antipsychotic Agents
;
Autonomic Nervous System
;
Dibenzothiazepines
;
Emergencies
;
Female
;
Fever
;
Humans
;
Muscle Rigidity
;
Neuroleptic Malignant Syndrome
;
Renal Insufficiency
;
Young Adult
;
Quetiapine Fumarate

Result Analysis
Print
Save
E-mail